1588 results found | searching for "property"

First Previous 1 2 3 4 5 6 7 8 9 10 Next Last 
  • bhuvi112233
  • Signature Global Prime in Sector-63A, one of the impending under-development lodging social orders in Gurgaon. There are condos and autonomous floors available to be purchased in Signature Global Prime. This general public will have every single essential office and conveniences to suit homebuyer's necessities and prerequisites. Brought to you by Signature Global, Signature Global Prime is booked for ownership in Oct, 2023. This lodging society brings different property choices to the table, in fluctuated cost range, making it one of the most reasonable location to claim, that too in your spending plan. For Details contact Bhuvi Realtech to get a statement - +91-9818526663 https://sector63gurgaon.in/property/signature-global/
  • bhuvi112233
  • Dhoot Time Residency in Sector-63, Gurgaon is a prepared to-move lodging society. It offers lofts and studio condos in fluctuated financial plan range. These units are an ideal blend of solace and style, explicitly intended to suit your necessities and comforts. There are 2BHK and 3BHK lofts and 1RK studio condos accessible in this venture. This lodging society is presently fit to be called home as families have begun moving in. Look at a portion of the highlights of Dhoot Time Residency lodging society: *Dhoot Time Residency Sector-63 has 9 pinnacles, with 19 stories each and 609 units on offer. *Spread over an area of 9.18 sections of land, Dhoot Time Residency is one of the roomy lodging social orders in the Gurgaon locale. With every one of the fundamental conveniences accessible. Bhuvi Realtech top leading company in real estate industry in Gurgaon. Contact us for details 9582000023 https://sector63gurgaon.in/property/dhoot-time-residency/
  • jameshebrew
  • The novel cardiovascular drug delivery devices market is projected to grow at a CAGR of 9.3%, till 2035, claims Roots Analysis Given the growing number of patients suffering from cardiovascular disorders and the high associated financial burden, cardiovascular drug eluting stents have emerged as a safe and efficient novel drug delivery device to assist in providing effectual treatment. Roots Analysis has announced the addition of “Novel Cardiovascular Drug Delivery Devices Market, 2022-2035” report to its list of offerings. In order to prevent the critical effects of vessel narrowing and plaque buildup in arteries, various coronary interventional devices are being used; cardiovascular stents have emerged as one of the most preferred solutions to mitigate the aforementioned concerns. Traditionally, bare-metal stents were used extensively to open the blocked passages and restore adequate blood flow to the heart. However, in recent years, a shift in preference has been observed towards the use of drug-eluting stents, which are coated with a polymer carrying an antiproliferative drug. Key Market Insights Over 90 cardiovascular drug eluting stents are presently available in this market space About 65% of these devices are coated with sirolimus drug, followed by those coated with everolimus and paclitaxel. Further, more than 70% of the stents are manufactured by using cobalt alloy. It is interesting to mention that stent length of more than 85% of the devices is in the range of 31 mm to 50 mm. ~40 players are currently be engaged in the production of cardiovascular drug eluting stents Majority of the players engaged in this domain are large firms (501-10,000 employees, 41%), followed by mid-sized players (51-500 employees, 26%), very large players (10,000+ employees, 18%) and small (2-50 employees, 15%) companies. Additionally, most of the service providers (38%) are based in Asia, followed by those having headquarters in Europe and North America. Over 70 novel therapeutics are being developed to target a wide range of cardiovascular diseases Majority (50%) of the therapies targeting cardiovascular disorder are currently in early stages of development (discovery and preclinical). It is also worth mentioning that over 65% of the drug candidates targeting cardiovascular diseases are gene therapies. More than 50 players are engaged in offering novel cardiovascular-based services / solutions Over 60% of the players offering such services / solutions are based in North America. It is interesting to mention that this domain is dominated (more than 40%) by the players offering digital therapeutics services. Till date, 900+ patents have been filed related to novel cardiovascular drug delivery devices In terms of the intellectual property developed across the world, the R&D activity is currently concentrated in North America and Europe. Further, most patented inventions are focused on the development of bioresorbable and biodegradable drug eluting stents. Global demand for novel cardiovascular drug delivery devices is anticipated to grow at a CAGR of over 13%, during 2022-2035 In 2035, sirolimus eluting stents are expected to contribute over 50% of the total demand for novel cardiovascular drug delivery devices, majority (~70%) of such devices are manufactured using cobalt chromium as a stent material. Players based in North America are anticipated to capture over 80% of the market share by 2035 The overall market of novel cardiovascular drug delivery devices is expected to be primarily driven by the rising demand for therapeutic interventions and recent technology advancements in the field. The estimates in our report suggest that stents manufactured using cobalt chromium are expected to hold more than 70% of the market share in 2035. It is interesting to mention that the market for stents manufactured using platinum chromium are expected to grow at a relatively faster pace (11.5%), during the forecast period. To request a sample copy / brochure of this report, please visit this https://www.rootsanalysis.com/reports/novel-cardiovascular-drug-delivery-devices-market/request-sample.html Key Questions Answered  Who are the leading players engaged in offering cardiovascular drug eluting stents?  Which type of drug eluting stent is most commonly offered by developers engaged in this market space?  What is the relative competitiveness of players engaged in the development / manufacturing of cardiovascular drug eluting stents?  How has the patent landscape in this domain evolved over the last two decades?  What is the present and likely future demand for cardiovascular drug eluting stents in the overall healthcare sector?  What are the anticipated future trends related to cardiovascular drug eluting stents market?  How is the current and future opportunity likely to be distributed across key market segments? The financial opportunity within the novel cardiovascular drug delivery devices market has been analyzed across the following segments:  Type of Drug Eluted  Sirolimus  Paclitaxel  Everolimus  Zotarolimus  Others  Type of Stent Material  Cobalt Chromium  Platinum Chromium  Stainless Steel  Others  Key Geographical Regions  North America  Europe  Asia  Middle East and North Africa  Latin America  Rest of the World The research includes profiles of key players (listed below); each profile features a brief overview of the company, details related to its recent developments (including funding and collaborations) and an informed future outlook.  Alvimedica  B. Braun  Boston Scientific  Cook Medical  Eurocor Scientific  Lepu Medical  Medtronic  Meril  Relisys  Sahajanand Medical Technologies For additional details, please visit https://www.rootsanalysis.com/reports/novel-cardiovascular-drug-delivery-devices-market.html or email sales@rootsanalysis.com You may also be interested in the following titles: 1. Targeted protein degradation market, 2022-2035 2. Cell Therapy Manufacturing Market, 2021-2030 3. Single-Use Upstream Bioprocessing Technology / Equipment Market, 2022-2035 About Roots Analysis Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com Contact: Ben Johnson +1 (415) 800 3415 +44 (122) 391 1091 Ben.johnson@rootsanalysis.com Facebook - https://www.facebook.com/RootsAnalysis LinkedIn - https://www.linkedin.com/company/roots-analysis/mycompany/ Twitter - https://twitter.com/RootsAnalysis Medium - https://medium.com/@RootsAnalysis Pinterest - https://in.pinterest.com/RootsanalysisPin/_saved/ Quora - https://rootsanalysisinsights.quora.com/ [more]
  • saulcreative
  • Satellite Mapping shows proximity and terrain three-dimensionally. We use Google Earth to show the homes' property lines, label nearby areas, and create 3D flyovers. Photographers Bozeman MT can increase your listing or small business exposure exponentially. https://www.saulcreative.com/
  • jameshebrew
  • The needlestick safety injection devices market is anticipated to grow at a commendable pace by 2035, claims Roots Analysis An exponential increase in the annual cost burden due to needlestick injuries, has fueled a corresponding rise in demand for safe and highly advanced safety devices to be developed by the stakeholders engaged in the healthcare industry to generate a stringent regulation for the prevention of needle-stick injuries. Roots Analysis has announced the addition of “Needlestick Safety Injection Devices Market, 2022-2035” report to its list of offerings. Given the inherent benefits of needlestick safety injection devices, number of developers have launched their proprietary devices for minimizing the risk of needlestick injuries. Moreover, stringent regulatory requirements have further prompted the stakeholders to improve product design and integrate better safety measures in their products, including needle shielding. Key Market Insights Currently, around 120 needlestick safety injection devices are available in the market More than 35% of these injection devices are needles having the ability to retract or shield, followed by syringes (30%). It is worth noting that more than 90% of the needlestick safety injection devices are non-reusable (intended for single use) thereby reducing the chances of blood borne pathogen infections. Over 50 companies claim to develop needlestick safety injection devices, worldwide Presently, the market is dominated by very small companies (33%) and small companies (25%). It is worth noting that majority (40%) of the firms engaged in this domain are based in Europe, followed by North America (39%). Partnership activity within this field has grown significantly between 2020 and 2022 Maximum number of partnerships (31%) were established in 2020 indicating a recent rise in the interest of developers engaged in the development of needlestick safety injection devices. It is worth highlighting that majority of the deals were acquisitions. Over USD 260 million has been invested by both private and public investors, since 2016 Companies involved in the development of needlestick safety injection devices have raised around USD 70 million through venture funding, which represents 25% of the total capital raised in the given time period. Overall, around 20 investors have actively financed various projects / initiatives in this domain. Close to 20 global events were organized in the past couple of years in this industry Majority of the events related to needlestick safety injection device were organized in North America (22%). It is worth highlighting that the main agenda of these events was to discuss role of needlestick safety injection devices to prevent the needlestick injuries. More than 140 patents have been filed / granted related to needlestick safety injection devices, since 2018 Of these, over 60 patents were filed / granted in 2022 (till April). Industry players that have filed maximum number of patents related to needlestick safety injection devices include (in decreasing order of number of patents filed) BD, West Pharmaceutical Services, B. Braun, Retractable Technologies and Safety Syringes. North America and Europe are anticipated to capture more than 75% of the market by 2035 Growth in this domain is anticipated to be primarily driven by the rising cases of needlestick injuries amongst the healthcare workers. The Asia-Pacific needlestick safety injection devices market currently accounts for more than 20% of the global market. To request a sample copy / brochure of this report, please visit this https://www.rootsanalysis.com/reports/needlestick-safety-market/request-sample.html Key Questions Answered  Who are the leading needlestick safety injection devices developers?  Which are the popular types of safety injection devices available in this market?  What are the key challenges faced by stakeholders engaged in the development of needlestick safety injection devices?  What types of partnership models are commonly being adopted by stakeholders in this industry?  How has the intellectual property landscape of needlestick safety injection devices developers evolved over the years?  Which factors are likely to influence the evolution of this market?  How is the current and future market opportunity likely to be distributed across key market segments? The research also includes detailed profiles of key players (listed below), each profile features an overview of the company, its financial information (if available), details on product portfolio, recent developments, and an informed future outlook.  B. Braun  BD  Gerresheimer  HTL-STREFA  Nipro Europe Group Companies  SOL-MILLENNIUM Medical Group For additional details, please visit https://www.rootsanalysis.com/reports/needlestick-safety-market.html or email sales@rootsanalysis.com You may also be interested in the following titles: 1. Targeted protein degradation market, 2022-2035 2. Cell Therapy Manufacturing Market, 2021-2030 3. Single-Use Upstream Bioprocessing Technology / Equipment Market, 2022-2035 About Roots Analysis Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com Contact: Ben Johnson +1 (415) 800 3415 +44 (122) 391 1091 Ben.johnson@rootsanalysis.com Facebook - https://www.facebook.com/RootsAnalysis LinkedIn - https://www.linkedin.com/company/roots-analysis/mycompany/ Twitter - https://twitter.com/RootsAnalysis Medium - https://medium.com/@RootsAnalysis Pinterest - https://in.pinterest.com/RootsanalysisPin/_saved/ Quora - https://rootsanalysisinsights.quora.com/ [more]
  • PropertyXpo
  • bhuvi112233
  • Bhuvi Realtech is here to show you Birla Navya, Sector 63A - Gurugram is spread over an area of roughly 1,90,202 square meters. The township lodging project incorporates five individual pockets guaranteeing the right floor region proportion for serene living. Selective and autonomous floor units make premium floor homes at Birla Navya on the ball. The homes are created with an excellent spotlight on maintainability. The primary advancement stage at Birla Navya, Sector 63A - Gurugram incorporates three pockets — Drisha 1A, Amoda I and Amoda II. The planned scenes, highlighting trees and vegetation, are likewise omnipresent to a specific pocket. For additional subtleties contact bhuvi realtech. https://sector63gurgaon.in/property/birla-navya-premium-low-rise-floors/
  • bhuvi112233
  • Bhuvi Realtech with Residential undertaking, Roseate 63 in Gurgaon is making units available for purchase in Kadarpur. Look at a few Apartment that suit your way of life and loving. Ownership date of Roseate 63 is Dec, 2022. The property offers 4 BHK units. According to the area plan, units are in the size scope of 1710.0 - 2178.0 sq.ft.. This private venture was sent off in March 2022. Regarding offices, Roseate 63 is stacked with different contributions like Power Backup. It is a Gated Community. There is 24×7 Security. Unmistakable rural areas of Gurgaon are nearby to Kadarpur and with a few schools, medical clinics, banks and workplaces arranged in the closeness, the task is a favored decision for home searchers. for more data contact Bhuvi Realtech https://sector63gurgaon.in/property/roseate-63-4bhk-luxurious-apartment/ [more]
  • hydservice
  • Landscape in hyderabad Beyond Scapes has gradually become one of the most trusted landscaping companies in Hyderabad. We are a group of architects, landscape designers, outdoor planners, quality surveyors and high-end property developers who work on principles of excellent workmanship, customer satisfaction, and real care. https://beyondscapes.in/
  • saulcreative
  • Is It Helpful to Hire Professional Photographers Bozeman MT? We provide one of the best services for Photographers Bozeman MT. you can rely on us to provide you with the best services possible. Our professionals will work according to the property site seeing and also according to what will be your needs. Do not hesitate to contact us through the details below. https://www.saulcreative.com/
First Previous 1 2 3 4 5 6 7 8 9 10 Next Last